Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues

CNBC2021-05-08

KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Lcc73
2021-05-10
Lcc73
Like n comment
Lynny
2021-05-09
Lynny
Why am I not surprised. Big Pharma will do what they do best. Come up with all sorts ofreasons and arguments to protect their intellectual property. None is going to be altruistic and generous about sharing and releasing their patents. Even if it means it might help save more lives in poorer countries. It would mean less profits for them and their shareholders. And at the end of the day they’re still a profit-driven company.. ?
gneh
2021-05-09
gneh
Very profit driven. This life saving solutions shld be more regulated to help more ppl in the world
- Sumei:
  They did spend a loT of $ on R&D
- Lynny:
  Yes they are all going to try to protect their turf
Winner168
2021-05-09
Winner168
Great news for All vaccine stocks
LY1970
2021-05-08
LY1970
Not a good idea
- James3128:
  Help Me comment back
ApacheFire
2021-05-08
ApacheFire
Some truth in it but most probably, do not want the formulation to be disclosed which would affect revenue and profit if they do so.

Leave a comment

191

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106240370?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-08 08:03","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1106240370","market":"hk","top_or_hot":-1,"title":"Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues","media":"CNBC","content":"<div>\n<p>KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 08:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html","article_id":"1106240370","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/05/07/pfizer-ceo-biden-backed-covid-vaccine-patent-waiver-will-cause-problems.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1106240370","pubTimestamp":1620432184,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines ","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞首席执行官反对美国要求放弃Covid疫苗专利，并提出制造和安全问题","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"KEY POINTSPfizer CEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of Covid shots.The Biden administration endorsed the waiver proposal days earlier, in service of expanding vaccine distribution to lower-income nations currently being battered by the pandemic.But Bourla, whose company produces one of three vaccines approved for emergency use in the U.S., said he believes \"categorically\" that the waiver proposal will \"create more problems.\"PfizerCEO Albert Bourla warned Friday that waiving patent protections for Covid vaccines —a proposal President Joe Biden just endorsed— would set off a worldwide race for raw materials that threatens the safe and efficient manufacturing of Covid shots.The Biden administration said Wednesday it supports the limited waiver of intellectual property rules in service of expanding vaccine distribution to the lower-income nations currently being battered bythe pandemic.But Bourla, whose company produces one of three vaccines approved for emergency use in the U.S., said that he believes “categorically” that the waiver proposal will “create more problems.”“Currently, infrastructure is not the bottleneck for us manufacturing faster,” Bourla wrote in a dear colleagueletter posted on LinkedIn. “The restriction is the scarcity of highly specialized raw materials needed to produce our vaccine.”Pfizer’s vaccine requires 280 different materials and components that are sourced from 19 countries around the world, Bourla said. He contended that without patent protections, entities with much less experienced than Pfizer at manufacturing vaccines will start competing for the same ingredients.“Right now, virtually every single gram of raw material produced is shipped immediately into our manufacturing facilities and is converted immediately and reliably to vaccines that are shipped immediately around the world,” Bourla wrote.He predicted that the proposed waiver “threatens to disrupt the flow of raw materials.”“It will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine,” Bourla wrote.“Entities with little or no experience in manufacturing vaccines are likely to chase the very raw materials we require to scale our production, putting the safety and security of all at risk,” the CEO wrote.The White House referred CNBC’s outreach on Bourla’s post to the Office of U.S. Trade Representative, which did not immediately respond to a request for comment.World Trade Organization leaders have recently urged member nations to come to an agreement on the potential vaccine patent waivers. But even with the U.S. backing, a deal is hardly guaranteed, since the WTO’s rulings are based on consensus, requiring approval from all 164 members.Germany, a WTO member and the largest economy in Europe, came out against the waiver proposal on Thursday.BioNTech, which partnered with Pfizer in developing the vaccine, is based in Germany.Bourla on LinkedIn also expressed concern that the possible vaccine waivers “will disincentivize anyone else from taking a big risk.”“The recent rhetoric will not discourage us from continuing investing in science. But I am not sure if the same is true for the thousands of small biotech innovators that are totally dependent on accessing capital from investors who invest only on the premise that their intellectual property will be protected,” the CEO wrote.PhRMA, the pharmaceutical industry interest groups whosemember companies includePfizer andJohnson & Johnson, another U.S. vaccine provider, called the waiver proposal “an unprecedented step that will undermine our global response to the pandemic and compromise safety.”Meanwhile, CEO Stephane Bancel ofModerna, maker of the other U.S.-approved Covid shot, saidhe wasn’t concerned about the possible waivers.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":190380856,"gmtCreate":1620599516075,"gmtModify":1704345181399,"author":{"id":"3564712937580301","authorId":"3564712937580301","name":"Lcc73","avatar":"https://static.tigerbbs.com/72523840e673b42dada1978a1dc74033","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3564712937580301","authorIdStr":"3564712937580301"},"htmlText":"Like n comment","listText":"Like n comment","text":"Like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190380856","repostId":1106240370,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":190952455,"gmtCreate":1620574738377,"gmtModify":1704345100689,"author":{"id":"3576275613425159","authorId":"3576275613425159","name":"Lynny","avatar":"https://static.tigerbbs.com/7c0b8b78e97626dedf9ed61da1957ab7","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3576275613425159","authorIdStr":"3576275613425159"},"htmlText":"Why am I not surprised. Big Pharma will do what they do best. Come up with all sorts ofreasons and arguments to protect their intellectual property.&nbsp;None is going to be altruistic and generous about sharing and releasing their patents. Even if it means it might help save more lives in poorer countries.&nbsp;It would mean less profits&nbsp;for them and their shareholders.&nbsp;And at the end of the day they’re still a profit-driven company.. ?","listText":"Why am I not surprised. Big Pharma will do what they do best. Come up with all sorts ofreasons and arguments to protect their intellectual property.&nbsp;None is going to be altruistic and generous about sharing and releasing their patents. Even if it means it might help save more lives in poorer countries.&nbsp;It would mean less profits&nbsp;for them and their shareholders.&nbsp;And at the end of the day they’re still a profit-driven company.. ?","text":"Why am I not surprised. Big Pharma will do what they do best. Come up with all sorts ofreasons and arguments to protect their intellectual property. None is going to be altruistic and generous about sharing and releasing their patents. Even if it means it might help save more lives in poorer countries. It would mean less profits for them and their shareholders. And at the end of the day they’re still a profit-driven company.. ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190952455","repostId":1106240370,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":190080210,"gmtCreate":1620552454830,"gmtModify":1704344914109,"author":{"id":"3581305522347138","authorId":"3581305522347138","name":"gneh","avatar":"https://static.tigerbbs.com/f2ea19968f55648d955b9ad2de4952c1","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":0,"idStr":"3581305522347138","authorIdStr":"3581305522347138"},"htmlText":"Very profit driven. This life saving solutions shld be more regulated to help more ppl in the&nbsp;world","listText":"Very profit driven. This life saving solutions shld be more regulated to help more ppl in the&nbsp;world","text":"Very profit driven. This life saving solutions shld be more regulated to help more ppl in the world","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/190080210","repostId":1106240370,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4272486,"gmtCreate":1620580492182,"gmtModify":1680787766748,"authorId":3566259831309087,"author":{"id":3566259831309087,"idStr":"3566259831309087","authorId":3566259831309087,"name":"Sumei","avatar":"https://static.tigerbbs.com/ae0a2af1baf6b07a87ffdf41ea17959a","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":190080210,"type":1,"supId":4272087,"prevId":0,"content":"They did spend a loT of $ on R&amp;D","text":"They did spend a loT of $ on R&amp;D","html":"They did spend a loT of $ on R&amp;D"},{"id":4272087,"gmtCreate":1620574395586,"gmtModify":1680787764374,"authorId":3576275613425159,"author":{"id":3576275613425159,"idStr":"3576275613425159","authorId":3576275613425159,"name":"Lynny","avatar":"https://static.tigerbbs.com/7c0b8b78e97626dedf9ed61da1957ab7","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":190080210,"type":1,"supId":0,"prevId":0,"content":"Yes they are all going to try to protect their turf","text":"Yes they are all going to try to protect their turf","html":"Yes they are all going to try to protect their turf"}],"langContent":"EN"},{"id":107596154,"gmtCreate":1620520166578,"gmtModify":1704344478156,"author":{"id":"3575410552110704","authorId":"3575410552110704","name":"Winner168","avatar":"https://static.tigerbbs.com/a9a80312562b6000414b8ef5ff5b400f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575410552110704","authorIdStr":"3575410552110704"},"htmlText":"Great news for All vaccine stocks","listText":"Great news for All vaccine stocks","text":"Great news for All vaccine stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107596154","repostId":1106240370,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":107660784,"gmtCreate":1620481956248,"gmtModify":1704344259046,"author":{"id":"3581643786644012","authorId":"3581643786644012","name":"LY1970","avatar":"https://static.tigerbbs.com/99deb9932439b87c6072806b53ff4f0b","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581643786644012","authorIdStr":"3581643786644012"},"htmlText":"Not a good idea","listText":"Not a good idea","text":"Not a good idea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/107660784","repostId":1106240370,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4265639,"gmtCreate":1620518150780,"gmtModify":1680787664181,"authorId":3554270654692944,"author":{"id":3554270654692944,"idStr":"3554270654692944","authorId":3554270654692944,"name":"James3128","avatar":"https://static.tigerbbs.com/5ace08c09b102c90559617c6182a8216","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.50%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":9,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":107660784,"type":1,"supId":0,"prevId":0,"content":"Help Me comment back ","text":"Help Me comment back ","html":"Help Me comment back "}],"langContent":"EN"},{"id":107971697,"gmtCreate":1620441993019,"gmtModify":1704343774041,"author":{"id":"3560730969024945","authorId":"3560730969024945","name":"ApacheFire","avatar":"https://community-static.tradeup.com/news/dadb20729b4de235c5471810de88a90d","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":7,"crmLevelSwitch":1,"idStr":"3560730969024945","authorIdStr":"3560730969024945"},"htmlText":"Some truth in it but most probably, do not want the formulation to be disclosed which would affect revenue and profit if they do so.&nbsp;","listText":"Some truth in it but most probably, do not want the formulation to be disclosed which would affect revenue and profit if they do so.&nbsp;","text":"Some truth in it but most probably, do not want the formulation to be disclosed which would affect revenue and profit if they do so.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/107971697","repostId":1106240370,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":191,"commentSize":76,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106240370"}